NICE backs new option for Crohn’s disease
admin 28th April 2017 Uncategorised 0The National Institute for Health and Care Excellence is backing the use of Janssen’s biologic Stelara to treat adult patients with moderately to severely active Crohn’s disease.
More: NICE backs new option for Crohn’s disease
Source: News